RE:RE:RE:RE:RE:investor materialsHas anyone here owned a tech stock or micro bio-pharma that had patents nailed down and a very promising drug or software? I have and the only way they might relate to a company like GROW is that they all were in embryo stage with little or no revenues and were bought out for a mind-boggling multiple. This technology as it proves out should be no different than the aforementioned. Think global once it all catches on but it will be owned by another company and not in Canada. GLTA